Statement of Cash Flows	7 Months Ended
	Dec. 31, 2020 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (1,512,369)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(108,848)
Unrealized gain on marketable securities held in Trust Account	(14,837)
Changes in operating assets and liabilities:
Prepaid expenses	(145,771)
Accrued expenses	1,087,789
Net cash used in operating activities	(694,036)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(319,453,440)
Net cash used in investing activities	(319,453,440)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	313,064,371
Proceeds from sale of Private Placement Warrants	8,139,069
Proceeds from promissory note – related party	142,931
Repayment of promissory note – related party	(142,931)
Payment of offering costs	(431,681)
Net cash provided by financing activities	320,771,759
Net Change in Cash	624,283
Cash – Beginning of period
Cash – End of period	624,283
Non-Cash investing and financing activities:
Initial classification of common stock subject to possible redemption	304,589,870
Change in value of common stock subject to possible redemption	(1,511,355)
Deferred underwriting fee payable	11,180,870
Offering costs paid directly by Sponsor in exchange for the issuance of common stock	$ 25,000